These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

118 related articles for article (PubMed ID: 3428346)

  • 1. Metabolic effects of long-term therapy with muzolimine and chlorthalidone in hypertension.
    Galletti F; Strazzullo P; Gagliardi R; Cirillo M; Siani A; Iacone R; Mancini M
    Eur J Clin Pharmacol; 1987; 33(5):515-7. PubMed ID: 3428346
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Interference on metabolism induced by muzolimine and chlorthalidone in type II hypertensive diabetics.
    Pagano G; Dal Molin V; Bozzo C; Carta Q
    Z Kardiol; 1985; 74 Suppl 2():80-3. PubMed ID: 3890395
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Cross-over study of muzolimine and hydrochlorothiazide-amiloride in hypertensive patients.
    Ferrara LA; Strazzullo P; Scillitani A; Mancini M; Gagliardi R
    Eur J Clin Pharmacol; 1985; 28(3):241-4. PubMed ID: 4007027
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Influence of muzolimine and other diuretics on human red cell Na+, K+-cotransport.
    Knorr A; Garthoff B; Ingendoh A; De Mendonça M
    Z Kardiol; 1985; 74 Suppl 2():175-8. PubMed ID: 4002796
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Muzolimine: a new high-ceiling diuretic suitable for patients with advanced renal disease.
    Dal Canton A; Russo D; Gallo R; Conte G; Andreucci VE
    Br Med J (Clin Res Ed); 1981 Feb; 282(6264):595-8. PubMed ID: 6781585
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Comparison of the effects of muzolimine and a fixed combination of diuretics in essential hypertension.
    Wicker P; Clementy J
    Clin Pharmacol Ther; 1986 May; 39(5):537-42. PubMed ID: 3516511
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Comparative pharmacodynamics of furosemide and muzolimine in cirrhosis. Study on renal sodium and potassium handling and renin-aldosterone axis.
    Bernardi M; De Palma R; Trevisani F; Santini C; Servadei D; Gasbarrini G
    Z Kardiol; 1985; 74 Suppl 2():129-34. PubMed ID: 3890391
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Treatment of mild to moderate essential hypertension with muzolimine. Two years of follow-up.
    Amabile G; Serradimigni A
    Z Kardiol; 1985; 74 Suppl 2():48-51. PubMed ID: 4002804
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Comparative study of muzolimine and acebutolol in the treatment of moderate hypertension.
    Lucsko M; Kerihuel JC; Chaignon M; Aubert PH; Guedon J
    Z Kardiol; 1985; 74 Suppl 2():73-6. PubMed ID: 3890394
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Muzolimine in advanced chronic renal failure.
    Mastrangelo F; Rizzelli S; Corlianò C; Alfonso L; De Blasi V; Aprile M; Montinaro AM; Napoli M
    Z Kardiol; 1985; 74 Suppl 2():109-14. PubMed ID: 4002783
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Muzolimine in the treatment of essential arterial hypertension not controlled with other antihypertensive drugs.
    Beneitez C
    Z Kardiol; 1985; 74 Suppl 2():52-5. PubMed ID: 4002805
    [TBL] [Abstract][Full Text] [Related]  

  • 12. [Clinical and hemodynamic effects of medium-term treatment with muzolimine in subjects with essential arterial hypertension].
    Licata G; Scaglione R; Parrinello G; Rini GB; Asta N
    G Ital Cardiol; 1986 Jul; 16(7):583-5. PubMed ID: 3781147
    [TBL] [Abstract][Full Text] [Related]  

  • 13. [Pharmacodynamic and pharmacokinetic studies of muzolimine in patients with hepatogeneous ascites (author's transl)].
    Loew D; Dýcka J; Pfleiderer T; Ritter W
    Z Gastroenterol; 1980 Oct; 18(10):537-42. PubMed ID: 7456563
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Short-term, high-dose muzolimine treatment in patients with chronic renal failure and acute fluid retention.
    Orsoni G; Di Felice A; Hadjigavriel M; Biavati M; Bonomini V
    Z Kardiol; 1985; 74 Suppl 2():121-4. PubMed ID: 4002785
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Pharmacokinetics and saluretic effect of muzolimine in severe cardiac failure.
    Brørs O; Fauchald P; Lind E; Jacobsen S
    Curr Med Res Opin; 1980; 6(6):431-6. PubMed ID: 7363644
    [TBL] [Abstract][Full Text] [Related]  

  • 16. [Intraerythrocytic potassium and diuretic therapy].
    Otto GL; de Carvalho JG; Laffitte A; Baroni G
    Arq Bras Cardiol; 1989 Feb; 52(2):91-3. PubMed ID: 2596994
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Effects of a new loop diuretic (muzolimine) in cirrhosis with ascites: comparison with furosemide.
    Bernardi M; De Palma R; Trevisani F; Santini C; Patrono D; Motta R; Servadei D; Gasbarrini G
    Hepatology; 1986; 6(3):400-5. PubMed ID: 3519416
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Clinical evaluation of muzolimine and indapamide during treatment for essential hypertension.
    Kirsten R; Molz KH; Tzonev I; Nelson K
    Z Kardiol; 1985; 74 Suppl 2():66-72. PubMed ID: 4002807
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Muzolimine therapy in patients with congestive heart failure in comparison with furosemide pretreatment. Effect on digoxin plasma concentration.
    Kahles H; Ertl G; Riegger G; Liebau G; Kochsiek K
    Z Kardiol; 1985; 74 Suppl 2():24-6. PubMed ID: 4002799
    [TBL] [Abstract][Full Text] [Related]  

  • 20. [Muzolimine in liver cirrhosis and essential arterial hypertension].
    Salerno L; Pepe S; Sallì L; Scalici G; Curiale B; Salvato F
    Clin Ter; 1986 Jul; 118(2):99-107. PubMed ID: 3742982
    [No Abstract]   [Full Text] [Related]  

    [Next]    [New Search]
    of 6.